Exact Sciences Corp
(NAS:EXAS)
$
54.33
-0.39 (-0.71%)
Market Cap: 10.06 Bil
Enterprise Value: 11.87 Bil
PE Ratio: 0
PB Ratio: 3.13
GF Score: 80/100 Exact Sciences Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 13, 2022 / 10:20PM GMT
Release Date Price:
$37.28
(-9.58%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome, everybody. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs. Thanks, everybody, for joining us today. I have the pleasure of welcoming Exact Sciences to the stage here. Kevin Conroy, the Chairman of the Board and Chief Executive Officer; and Everett Cunningham, Chief Commercial Officer. Kevin, Everett, thank you for joining us today.
Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO
Thanks, Matt.
Everett Cunningham
Thanks, Matt. Appreciate being here.
Questions & Answers
Matthew Carlisle Sykes;Kevin T. Conroy<
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Maybe we'll just start off and let you set stage for a little bit and kind of talk about some of the recent highlights so far this year and kind of what investors should be focused on as we enter the second half of '22?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot